查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575452

肺气肿治疗市场：按类型、治疗方法方式、患者类型、护理环境、给药途径- 全球预测 2025-2030

Emphysema Treatment Market by Type (Inhalation Drugs, Intravenous Drugs, Oral Drugs), Treatment (Medications, Surgeries, Therapies), Patient Type, Care Settings, Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肺气肿治疗市值为64亿美元，预计到2024年将达到68.3亿美元，复合年增长率为6.98%，预计到2030年将达到102.7亿美元。

肺气肿治疗市场的范围和定义涵盖了旨在管理这种慢性且不可逆转的肺部疾病的广泛医疗干预措施，其主要特征是气囊受损和气流阻塞。肺气肿严重损害生活品质，因此需要进行治疗以缓解症状并改善呼吸功能。药物治疗方法（如支气管扩张剂和皮质类固醇）和手术介入（如肺活量减少手术）均已应用。最终用途包括医院、诊所、家庭保健等。主要成长动力包括由于人口老化和污染水平上升而导致慢性阻塞性肺病（COPD）盛行率增加、药物开发的进步以及患者对微创手术的偏好增加。然而，潜在的成长机会在于扩大新兴市场的医疗基础设施以及开拓新的治疗方法，例如再生医学和人工智慧技术支援的个人化治疗计划。解决市场限制的挑战主要是由于严格的监管要求、与先进治疗方法相关的高成本以及进行呼吸系统疾病临床试验的独特复杂性。特定地区的经济不稳定也可能抑制市场扩张。创新的研究和开发领域包括开发可监测呼吸系统健康的可穿戴技术、促进远端患者管理的远端医疗的进步以及实现早期诊断和定制治疗的生物标记物的发现。市场是动态的，人们非常关注技术进步和向以患者为中心的整体护理模式的转变。希望发展业务的公司应该投资研发，以缓解挑战并利用新机会。製药公司、医疗保健提供者和技术公司之间的合作可以加速创新，并提高市场渗透率和患者治疗效果。随着市场在全球范围内不断扩张，关注具有成本效益且易于获得的治疗方案至关重要。

主要市场统计
基准年[2023] 64亿美元
预测年份 [2024] 68.3亿美元
预测年份 [2030] 102.7亿美元
复合年增长率（%） 6.98%

市场动态：揭示快速发展的肺气肿治疗市场的关键市场洞察

供需的动态交互作用正在改变肺气肿治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 吸烟率上升和污染水平上升导致肺气肿发生率上升
    • 促进肺气肿早期发现和治疗的诊断技术和技术的进步
    • 老年人口增多，老年人呼吸道疾病易感性高
    • 增加医疗支出和政府努力支持肺气肿的先进治疗方案
  • 市场限制因素
    • 由于新药和器械严格的监管核准流程导致市场准入延迟；
    • 农村地区肺气肿的认识和诊断率较低阻碍因素了市场成长
  • 市场机会
    • 肺气肿治疗越来越偏好微创手术治疗
    • 对治疗肺气肿的先进标靶给药系统的需求不断增长
    • 早期发现肺气肿的意识和筛检计划
  • 市场挑战
    • 进入市场的新肺气肿治疗药物面临监管障碍和漫长的核准时间
    • 由于复杂的剂量要求，患者对规定治疗方法的依从性较差

波特五力：开拓肺气肿治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肺气肿治疗市场的外部影响

外部宏观环境因素在塑造肺气肿治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解肺气肿治疗市场的竞争状况

肺气肿治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵肺气肿治疗市场供应商的绩效评估

FPNV定位矩阵是评估肺气肿治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了肺气肿治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对肺气肿治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 吸烟率的增加和空气污染水平的上升导致肺气肿的发生率增加
      • 促进肺气肿早期发现和治疗的诊断技术和技术的进步
      • 老年人口增加，老年人对呼吸道疾病的敏感度增加
      • 不断上涨的医疗成本和政府支持肺气肿先进治疗方案的努力
    • 抑制因素
      • 新肺气肿药物和医疗设备的严格监管核准程序减缓了市场准入
      • 农村地区肺气肿认知率和诊断率低阻碍市场成长
    • 机会
      • 微创手术治疗在肺气肿治疗中越来越受欢迎
      • 对治疗肺气肿的标靶和先进药物传输系统的需求不断增长
      • 早期发现肺气肿的意识提升和筛检计划
    • 任务
      • 新肺气肿治疗方法进入市场存在监管障碍和漫长的核准时间
      • 由于复杂的剂量要求，患者对规定治疗方案的依从性较差
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章肺气肿治疗市场：依类型

  • 吸入器
    • 抗胆碱能药物
    • 长效β受体激动剂（LABA）
    • 短效β受体激动剂（SABA）
  • 静脉注射药物
  • 口服药物
    • 皮质类固醇
    • 磷酸二酯酶 4 抑制剂（PDE4 抑制剂）

第七章 肺气肿治疗市场（依治疗方式）

  • 药品
    • 支气管扩张剂
    • 类固醇
  • 外科手术
    • 肺移植
    • 肺减容手术
  • 治疗方法
    • 氧气疗法
    • 呼吸復健

第八章按患者类型分類的肺气肿治疗市场

  • 成人用
  • 老年病
  • 小儿科

第九章依护理机构分類的肺气肿治疗市场

  • 诊所
  • 居家护理
  • 医院

第10章肺气肿治疗市场：依给药途径

  • 吸入
  • 口服
  • 胃肠外的

第十一章 北美和南美肺气肿治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区肺气肿治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的肺气肿治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C021A

The Emphysema Treatment Market was valued at USD 6.40 billion in 2023, expected to reach USD 6.83 billion in 2024, and is projected to grow at a CAGR of 6.98%, to USD 10.27 billion by 2030.

The scope and definition of the emphysema treatment market encompass a range of medical interventions aimed at managing this chronic, irreversible lung condition, primarily characterized by damaged air sacs and obstructed airflow. Necessity arises as emphysema significantly impairs quality of life, demanding treatments that alleviate symptoms and enhance respiratory function. Applications involve both pharmacological approaches, such as bronchodilators and corticosteroids, and surgical interventions, like lung volume reduction surgery. The end-use scope includes hospitals, clinics, and home healthcare settings. Key growth drivers include an increasing prevalence of chronic obstructive pulmonary disease (COPD) due to aging populations and rising pollution levels, alongside advances in drug development and increasing patient preference for minimally invasive procedures. However, potential growth opportunities lie in expanding healthcare infrastructure in emerging markets and the development of novel therapies, such as regenerative medicines or personalized treatment plans bolstered by AI technologies. Addressing market limitations, challenges primarily stem from stringent regulatory requirements, high costs associated with advanced treatment modalities, and the inherent complexities of conducting clinical trials for respiratory diseases. Economic instability in certain regions could also impede market expansion. Innovative research areas include the development of wearable technology to monitor respiratory health, advances in telemedicine to facilitate remote patient management, and biomarker discovery to enable earlier diagnosis and tailored therapies. The market is dynamic, with a significant focus on technological advancements and a shift towards holistic and patient-centric care models. Companies aiming for business growth should invest in R&D to mitigate challenges and capitalize on emerging opportunities. Collaborations between pharmaceutical firms, healthcare providers, and technology companies could accelerate innovation, leading to better market penetration and improved patient outcomes. Emphasizing cost-effective and accessible treatment options will be crucial as the market continues to expand globally.

KEY MARKET STATISTICS
Base Year [2023] USD 6.40 billion
Estimated Year [2024] USD 6.83 billion
Forecast Year [2030] USD 10.27 billion
CAGR (%) 6.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Emphysema Treatment Market

The Emphysema Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of smoking and rising pollution levels contributing to higher instances of emphysema
    • Advancements in diagnostic techniques and technologies facilitating early detection and treatment of emphysema
    • Growing geriatric population and higher susceptibility to respiratory diseases among the elderly
    • Rising healthcare expenditure and government initiatives supporting advanced treatment options for emphysema
  • Market Restraints
    • Stringent regulatory approvals process for new emphysema treatment drugs and devices causes delays in market entry
    • Low awareness and diagnosis rates of emphysema in rural areas hinder market growth
  • Market Opportunities
    • Increasing preference for minimally invasive surgical treatments for emphysema management
    • Growing demand for advanced drug delivery systems for targeted emphysema treatment
    • Rising awareness and screening programs for early detection of emphysema
  • Market Challenges
    • Regulatory hurdles and long approval times for new emphysema treatment therapies entering the market
    • Low patient adherence to prescribed treatment regimens due to complicated administration requirements

Porter's Five Forces: A Strategic Tool for Navigating the Emphysema Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Emphysema Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Emphysema Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Emphysema Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Emphysema Treatment Market

A detailed market share analysis in the Emphysema Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Emphysema Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Emphysema Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Emphysema Treatment Market

A strategic analysis of the Emphysema Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Emphysema Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Chiesi Farmaceutici S.p.A., Cipla Limited, CSL Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Grifols S.A., Merck & Co., Inc., Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Emphysema Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inhalation Drugs, Intravenous Drugs, and Oral Drugs. The Inhalation Drugs is further studied across Anticholinergics, Long-acting Beta-agonists (LABAs), and Short-acting Beta-agonists (SABAs). The Oral Drugs is further studied across Corticosteroids and Phosphodiesterase-4 inhibitors (PDE4 Inhibitors).
  • Based on Treatment, market is studied across Medications, Surgeries, and Therapies. The Medications is further studied across Bronchodilators and Steroids. The Surgeries is further studied across Lung Transplant and Lung Volume Reduction Surgery. The Therapies is further studied across Oxygen Therapy and Pulmonary Rehabilitation.
  • Based on Patient Type, market is studied across Adult, Geriatric, and Pediatric.
  • Based on Care Settings, market is studied across Clinics, Home Care, and Hospitals.
  • Based on Route of Administration, market is studied across Inhalation, Oral, and Parenteral.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of smoking and rising pollution levels contributing to higher instances of emphysema
      • 5.1.1.2. Advancements in diagnostic techniques and technologies facilitating early detection and treatment of emphysema
      • 5.1.1.3. Growing geriatric population and higher susceptibility to respiratory diseases among the elderly
      • 5.1.1.4. Rising healthcare expenditure and government initiatives supporting advanced treatment options for emphysema
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory approvals process for new emphysema treatment drugs and devices causes delays in market entry
      • 5.1.2.2. Low awareness and diagnosis rates of emphysema in rural areas hinder market growth
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing preference for minimally invasive surgical treatments for emphysema management
      • 5.1.3.2. Growing demand for advanced drug delivery systems for targeted emphysema treatment
      • 5.1.3.3. Rising awareness and screening programs for early detection of emphysema
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and long approval times for new emphysema treatment therapies entering the market
      • 5.1.4.2. Low patient adherence to prescribed treatment regimens due to complicated administration requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Emphysema Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Inhalation Drugs
    • 6.2.1. Anticholinergics
    • 6.2.2. Long-acting Beta-agonists (LABAs)
    • 6.2.3. Short-acting Beta-agonists (SABAs)
  • 6.3. Intravenous Drugs
  • 6.4. Oral Drugs
    • 6.4.1. Corticosteroids
    • 6.4.2. Phosphodiesterase-4 inhibitors (PDE4 Inhibitors)

7. Emphysema Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medications
    • 7.2.1. Bronchodilators
    • 7.2.2. Steroids
  • 7.3. Surgeries
    • 7.3.1. Lung Transplant
    • 7.3.2. Lung Volume Reduction Surgery
  • 7.4. Therapies
    • 7.4.1. Oxygen Therapy
    • 7.4.2. Pulmonary Rehabilitation

8. Emphysema Treatment Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Geriatric
  • 8.4. Pediatric

9. Emphysema Treatment Market, by Care Settings

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Home Care
  • 9.4. Hospitals

10. Emphysema Treatment Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Inhalation
  • 10.3. Oral
  • 10.4. Parenteral

11. Americas Emphysema Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Emphysema Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Emphysema Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AstraZeneca plc
  • 3. Bayer AG
  • 4. Boehringer Ingelheim International GmbH
  • 5. Chiesi Farmaceutici S.p.A.
  • 6. Cipla Limited
  • 7. CSL Limited
  • 8. Eli Lilly and Company
  • 9. F. Hoffmann-La Roche AG
  • 10. GlaxoSmithKline plc
  • 11. Grifols S.A.
  • 12. Merck & Co., Inc.
  • 13. Mylan N.V.
  • 14. Novartis International AG
  • 15. Pfizer Inc.
  • 16. Sanofi S.A.
  • 17. Sumitomo Dainippon Pharma Co., Ltd.
  • 18. Sun Pharmaceutical Industries Ltd.
  • 19. Takeda Pharmaceutical Company Limited
  • 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. EMPHYSEMA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. EMPHYSEMA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EMPHYSEMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. EMPHYSEMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMPHYSEMA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMPHYSEMA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LONG-ACTING BETA-AGONISTS (LABAS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SHORT-ACTING BETA-AGONISTS (SABAS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INTRAVENOUS DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE-4 INHIBITORS (PDE4 INHIBITORS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY LUNG VOLUME REDUCTION SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL EMPHYSEMA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES EMPHYSEMA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA EMPHYSEMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 247. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 257. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 287. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 307. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 327. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 337. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 341. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 342. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 343. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 344. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 345. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 346. NORWAY EMPHYSEMA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 347. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY INHALATION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 349. POLAND EMPHYSEMA TREATMENT MARKET SIZE, BY ORAL